Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancer

The expression of cyclooxygenase 2 (COX-2) was up-regulated and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) was significantly increased in colon cancer patients. As the main prostaglandin produced by COX-2, PGE<sub>2</sub> plays an important role in angiogenesis...

Full description

Bibliographic Details
Main Authors: ZHENG Lirong, DU Haoyang, ZHANG Ruifen, ZHANG Hairong, BAO Aruhan, YU Lei, CUI Hongwei
Format: Article
Language:zho
Published: The Editorial Department of Chinese Journal of Clinical Research 2023-09-01
Series:Zhongguo linchuang yanjiu
Subjects:
Online Access:http://zglcyj.ijournals.cn/zglcyj/ch/reader/view_abstract.aspx?file_no=20230912&flag=1
_version_ 1827808068902060032
author ZHENG Lirong
DU Haoyang
ZHANG Ruifen
ZHANG Hairong
BAO Aruhan
YU Lei
CUI Hongwei
author_facet ZHENG Lirong
DU Haoyang
ZHANG Ruifen
ZHANG Hairong
BAO Aruhan
YU Lei
CUI Hongwei
author_sort ZHENG Lirong
collection DOAJ
description The expression of cyclooxygenase 2 (COX-2) was up-regulated and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) was significantly increased in colon cancer patients. As the main prostaglandin produced by COX-2, PGE<sub>2</sub> plays an important role in angiogenesis, survival, invasion and migration of colon cancer cells. The EP<sub>4</sub> receptor, as an important transporter of PGE<sub>2</sub> signaling, increases the survival and development of colon cancer cells through various mechanisms of overexpression. Signal pathway starting from COX-2, continuing with PGE<sub>2</sub> and ending with EP<sub>4</sub> can promote the spread and growth of colon cancer. Therefore, targeting the COX-2/PGE<sub>2</sub>/EP<sub>4</sub> axis may be a valuable treatment method for colon cancer. This article outlines the biological activity of COX-2, the mechanism of action of COX-2/PGE<sub>2</sub>/EP<sub>4</sub> as a signal axis in colon cancer, and the research progress of targeted drugs in colon cancer prevention.
first_indexed 2024-03-11T22:06:12Z
format Article
id doaj.art-bb123b6c8ad843e1ad543faad28d2b41
institution Directory Open Access Journal
issn 1674-8182
language zho
last_indexed 2024-03-11T22:06:12Z
publishDate 2023-09-01
publisher The Editorial Department of Chinese Journal of Clinical Research
record_format Article
series Zhongguo linchuang yanjiu
spelling doaj.art-bb123b6c8ad843e1ad543faad28d2b412023-09-25T05:42:08ZzhoThe Editorial Department of Chinese Journal of Clinical ResearchZhongguo linchuang yanjiu1674-81822023-09-0136913381341,134710.13429/j.cnki.cjcr.2023.09.012Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancerZHENG Lirong0DU Haoyang1ZHANG Ruifen2ZHANG Hairong3BAO Aruhan4YU Lei5CUI Hongwei6Inner Mongolia Medical University, Hohhot, Inner Mongolia 010110, ChinaInner Mongolia Medical University, Hohhot, Inner Mongolia 010110, ChinaInner Mongolia Hospital of Traditional Chinese Medicine, Hohhot, Inner Mongolia 010000, ChinaInner Mongolia Hospital of Traditional Chinese Medicine, Hohhot, Inner Mongolia 010000, ChinaInner Mongolia Medical University, Hohhot, Inner Mongolia 010110, ChinaInner Mongolia Medical University, Hohhot, Inner Mongolia 010110, ChinaPeking University Oncology Hospital Inner Mongolia Hospital Inner Mongolia Medical University Affiliated Oncology Hospital, Hohhot, Inner Mongolia 010020, ChinaThe expression of cyclooxygenase 2 (COX-2) was up-regulated and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) was significantly increased in colon cancer patients. As the main prostaglandin produced by COX-2, PGE<sub>2</sub> plays an important role in angiogenesis, survival, invasion and migration of colon cancer cells. The EP<sub>4</sub> receptor, as an important transporter of PGE<sub>2</sub> signaling, increases the survival and development of colon cancer cells through various mechanisms of overexpression. Signal pathway starting from COX-2, continuing with PGE<sub>2</sub> and ending with EP<sub>4</sub> can promote the spread and growth of colon cancer. Therefore, targeting the COX-2/PGE<sub>2</sub>/EP<sub>4</sub> axis may be a valuable treatment method for colon cancer. This article outlines the biological activity of COX-2, the mechanism of action of COX-2/PGE<sub>2</sub>/EP<sub>4</sub> as a signal axis in colon cancer, and the research progress of targeted drugs in colon cancer prevention. http://zglcyj.ijournals.cn/zglcyj/ch/reader/view_abstract.aspx?file_no=20230912&flag=1cyclooxygenase 2prostaglandin e<sub>2</sub>ep<sub>4</sub> receptorcolon cancer; aspirin; celecoxib
spellingShingle ZHENG Lirong
DU Haoyang
ZHANG Ruifen
ZHANG Hairong
BAO Aruhan
YU Lei
CUI Hongwei
Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancer
Zhongguo linchuang yanjiu
cyclooxygenase 2
prostaglandin e<sub>2</sub>
ep<sub>4</sub> receptor
colon cancer; aspirin; celecoxib
title Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancer
title_full Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancer
title_fullStr Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancer
title_full_unstemmed Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancer
title_short Research progress on COX-2/PGE<sub>2</sub>/EP<sub>4</sub> signaling axis in colon cancer
title_sort research progress on cox 2 pge sub 2 sub ep sub 4 sub signaling axis in colon cancer
topic cyclooxygenase 2
prostaglandin e<sub>2</sub>
ep<sub>4</sub> receptor
colon cancer; aspirin; celecoxib
url http://zglcyj.ijournals.cn/zglcyj/ch/reader/view_abstract.aspx?file_no=20230912&flag=1
work_keys_str_mv AT zhenglirong researchprogressoncox2pgesub2subepsub4subsignalingaxisincoloncancer
AT duhaoyang researchprogressoncox2pgesub2subepsub4subsignalingaxisincoloncancer
AT zhangruifen researchprogressoncox2pgesub2subepsub4subsignalingaxisincoloncancer
AT zhanghairong researchprogressoncox2pgesub2subepsub4subsignalingaxisincoloncancer
AT baoaruhan researchprogressoncox2pgesub2subepsub4subsignalingaxisincoloncancer
AT yulei researchprogressoncox2pgesub2subepsub4subsignalingaxisincoloncancer
AT cuihongwei researchprogressoncox2pgesub2subepsub4subsignalingaxisincoloncancer